Howard Horn, CFO at Vir Biotechnology, Inc. (VIR), sold 20,000 shares at $40.00 ($778K) on 2020-07-02, disclosed to the SEC on 2020-07-02.
Open-market sale of $778k VIR by CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.72 | 9,100 | $343K | 44.1% |
| 2 | $38.78 | 500 | $19K | 2.5% |
| 3 | $39.33 | 400 | $16K | 2.0% |
| 4 | $40.00 | 10,000 | $400K | 51.4% |
| Total | $38.92 avg | 20,000 | $778K | 100% |
| Filing → |
| RARE | SELL | 2026-06-01 | $111K | — | Filing → |
| RARE | SELL | 2026-05-04 | $117K | — | Filing → |
| RARE | SELL | 2026-04-02 | $98K | — | Filing → |